{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:26:08Z","timestamp":1790364368759,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.trsl.2014.01.006","type":"journal-article","created":{"date-parts":[[2014,1,11]],"date-time":"2014-01-11T04:00:35Z","timestamp":1389412835000},"page":"46-56","source":"Crossref","is-referenced-by-count":30,"title":["Renal glucuronidation and multidrug resistance protein 2-\/ multidrug resistance protein 4-mediated efflux of mycophenolic acid: interaction with cyclosporine and tacrolimus"],"prefix":"10.1016","volume":"164","author":[{"given":"Azza A.K.","family":"El-Sheikh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan B.","family":"Koenderink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfons C.","family":"Wouterse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra H.H.","family":"van den Broek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivienne G.M.","family":"Verweij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalinde","family":"Masereeuw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans G.M.","family":"Russel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2014.01.006_bib1","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1358\/dot.2009.45.7.1384878","article-title":"Mycophenolate mofetil: an update","volume":"45","author":"Villarroel","year":"2009","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.trsl.2014.01.006_bib2","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.transproceed.2008.10.013","article-title":"Reviewing the evidence for de novo immunosuppression with sirolimus","volume":"40","author":"Flechner","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trsl.2014.01.006_bib3","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/ndt\/gfl844","article-title":"Use of mycophenolic acid in non-transplant renal diseases","volume":"22","author":"Stassen","year":"2007","journal-title":"Nephrol Dialysis Transplant"},{"key":"10.1016\/j.trsl.2014.01.006_bib4","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/sj.bjp.0703898","article-title":"Glucuronide and glucoside conjugation of mycophenolic acid by human liver, kidney and intestinal microsomes","volume":"132","author":"Shipkova","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.trsl.2014.01.006_bib5","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1517\/17425255.1.3.505","article-title":"Mycophenolate mofetil in organ transplantation: focus on metabolism, safety and tolerability","volume":"1","author":"Shipkova","year":"2005","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.trsl.2014.01.006_bib6","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.clinbiochem.2007.03.006","article-title":"Therapeutic drug measurement of mycophenolic acid derivatives in transplant patients","volume":"40","author":"Elbarbry","year":"2007","journal-title":"Clin Biochem"},{"key":"10.1016\/j.trsl.2014.01.006_bib7","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10928-009-9136-6","article-title":"Pharmacokinetic role of protein binding of mycophenolic acid and its glucuronide metabolite in renal transplant recipients","volume":"36","author":"de Winter","year":"2009","journal-title":"J Pharmacokinet Pharmacodynam"},{"key":"10.1016\/j.trsl.2014.01.006_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00003088-200746010-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients","volume":"46","author":"Staatz","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.trsl.2014.01.006_bib9","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/00007691-200110000-00003","article-title":"Effect of cyclosporine on mycophenolic acid area under the concentration-time curve in pediatric kidney transplant recipients","volume":"23","author":"Filler","year":"2001","journal-title":"Therapeutic Drug Monit"},{"key":"10.1016\/j.trsl.2014.01.006_bib10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00007691-200104000-00005","article-title":"Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid","volume":"23","author":"Van Gelder","year":"2001","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.trsl.2014.01.006_bib11","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.ftd.0000152682.13647.5e","article-title":"Influence of cyclosporine on the serum concentration and biliary excretion of mycophenolic acid and 7-O-mycophenolic acid glucuronide","volume":"27","author":"Deters","year":"2005","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.trsl.2014.01.006_bib12","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1124\/jpet.103.063073","article-title":"Cyclosporin A, but not tacrolimus, inhibits the biliary excretion of mycophenolic acid glucuronide possibly mediated by multidrug resistance-associated protein 2 in rats","volume":"309","author":"Kobayashi","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.trsl.2014.01.006_bib13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1124\/dmd.105.006122","article-title":"Role of Mrp2 in the hepatic disposition of mycophenolic acid and its glucuronide metabolites: effect of cyclosporine","volume":"34","author":"Westley","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.trsl.2014.01.006_bib14","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1046\/j.1600-6143.2005.00779.x","article-title":"Cyclosporine interacts with mycophenolic acid by inhibiting the multidrug resistance-associated protein 2","volume":"5","author":"Hesselink","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trsl.2014.01.006_bib15","first-page":"403","article-title":"Recent development of IMP dehydrogenase inhibitors for the treatment of cancer","volume":"10","author":"Chen","year":"2007","journal-title":"Curr Opin Drug Discov Dev"},{"key":"10.1016\/j.trsl.2014.01.006_bib16","first-page":"71","article-title":"Difference between pharmacokinetics of mycophenolic acid (MPA) in rats and that in humans is caused by different affinities of MRP2 to a glucuronized form","volume":"10","author":"Takekuma","year":"2007","journal-title":"J Pharm Pharm Sci"},{"key":"10.1016\/j.trsl.2014.01.006_bib17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ejphar.2008.02.085","article-title":"Mechanisms of renal anionic drug transport","volume":"585","author":"El-Sheikh","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.trsl.2014.01.006_bib18","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.tips.2008.01.006","article-title":"Multidrug resistance protein 4 (MRP4\/ABCC4): a versatile efflux transporter for drugs and signalling molecules","volume":"29","author":"Russel","year":"2008","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.trsl.2014.01.006_bib19","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/00498254.2012.713531","article-title":"Mycophenolic acid glucuronide is transported by multidrug resistance-associated protein 2 and this transport is not inhibited by cyclosporine, tacrolimus or sirolimus","volume":"43","author":"Patel","year":"2013","journal-title":"Xenobiotica"},{"key":"10.1016\/j.trsl.2014.01.006_bib20","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1124\/jpet.106.110379","article-title":"Interaction of nonsteroidal anti-inflammatory drugs with multidrug resistance protein (MRP) 2\/ABCC2- and MRP4\/ABCC4-mediated methotrexate transport","volume":"320","author":"El-Sheikh","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.trsl.2014.01.006_bib21","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1097\/01.ASN.0000094083.82845.FA","article-title":"Impaired renal secretion of substrates for the multidrug resistance protein 2 in mutant transport-deficient (TR\u2212) rats","volume":"14","author":"Masereeuw","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2014.01.006_bib22","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ejphar.2008.02.006","article-title":"Nitric oxide down-regulates the expression of organic cation transporters (OCT) 1 and 2 in rat kidney during endotoxemia","volume":"584","author":"Heemskerk","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.trsl.2014.01.006_bib23","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1124\/dmd.108.021428","article-title":"Expression of UGT1A and UGT2B mRNA in human normal tissues and various cell lines","volume":"36","author":"Nakamura","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.trsl.2014.01.006_bib24","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0278-6915(01)00088-6","article-title":"Uncertainty factors for chemical risk assessment: interspecies differences in glucuronidation","volume":"39","author":"Walton","year":"2001","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.trsl.2014.01.006_bib25","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1080\/00498250802488585","article-title":"Influence of uridine diphosphate (UDP)-glucuronosyltransferases and ABCC2 genetic polymorphisms on the pharmacokinetics of mycophenolic acid and its metabolites in Chinese renal transplant recipients","volume":"38","author":"Zhang","year":"2008","journal-title":"Xenobiotica"},{"key":"10.1016\/j.trsl.2014.01.006_bib26","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/clpt.2009.83","article-title":"UGT1A9 -275T>A\/-2152C>T polymorphisms correlate with low MPA exposure and acute rejection in MMF\/tacrolimus-treated kidney transplant patients","volume":"86","author":"van Schaik","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.trsl.2014.01.006_bib27","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/FTD.0b013e3182708f84","article-title":"UGT1A9, UGT2B7, and MRP2 genotypes can predict mycophenolic acid pharmacokinetic variability in pediatric kidney transplant recipients","volume":"34","author":"Fukuda","year":"2012","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.trsl.2014.01.006_bib28","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/00007691-200408000-00017","article-title":"Severe toxicity associated with a markedly elevated mycophenolic acid free fraction in a renal transplant recipient","volume":"26","author":"Mudge","year":"2004","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.trsl.2014.01.006_bib29","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.trim.2008.05.009","article-title":"The impact of P-glycoprotein and Mrp2 on mycophenolic acid levels in mice","volume":"19","author":"Wang","year":"2008","journal-title":"Transplant Immunol"},{"key":"10.1016\/j.trsl.2014.01.006_bib30","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/FTD.0b013e3181838063","article-title":"Influence of drug transporters and UGT polymorphisms on pharmacokinetics of phenolic glucuronide metabolite of mycophenolic acid in Japanese renal transplant recipients","volume":"30","author":"Miura","year":"2008","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.trsl.2014.01.006_bib31","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.2217\/pgs.10.132","article-title":"SLCO1B1 genetic polymorphism influences mycophenolic acid tolerance in renal transplant recipients","volume":"11","author":"Michelon","year":"2010","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.trsl.2014.01.006_bib32","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3109\/00498254.2011.573882","article-title":"Interaction of sirolimus and everolimus with hepatic and intestinal organic anion-transporting polypeptide transporters","volume":"41","author":"Picard","year":"2011","journal-title":"Xenobiotica"},{"key":"10.1016\/j.trsl.2014.01.006_bib33","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1124\/jpet.111.186916","article-title":"Expression of ATP-binding cassette membrane transporters in rodent and human Sertoli cells: relevance to the permeability of antiretroviral therapy at the blood-testis barrier","volume":"340","author":"Robillard","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.trsl.2014.01.006_bib34","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.phrs.2009.02.007","article-title":"Comparative gene expression profiles of ABC transporters in brain microvessel endothelial cells and brain in five species including human","volume":"59","author":"Warren","year":"2009","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.trsl.2014.01.006_bib35","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/FTD.0b013e318228195f","article-title":"Nonsteroidal anti-inflammatory drugs may reduce enterohepatic recirculation of mycophenolic acid in patients with childhood-onset systemic lupus erythematosus","volume":"33","author":"Fukuda","year":"2011","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.trsl.2014.01.006_bib36","doi-asserted-by":"crossref","first-page":"e18438","DOI":"10.1371\/journal.pone.0018438","article-title":"Uremic toxins inhibit transport by breast cancer resistance protein and multidrug resistance protein 4 at clinically relevant concentrations","volume":"6","author":"Mutsaers","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2014.01.006_bib37","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejps.2008.06.008","article-title":"Identification of interspecies difference in efflux transporters of hepatocytes from dog, rat, monkey and human","volume":"35","author":"Li","year":"2008","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.trsl.2014.01.006_bib38","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/j.1552-4604.1996.tb04207.x","article-title":"Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration","volume":"36","author":"Bullingham","year":"1996","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.trsl.2014.01.006_bib39","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1124\/dmd.108.021469","article-title":"Species differences in UDP-glucuronosyltransferase activities in mice and rats","volume":"36","author":"Shiratani","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.trsl.2014.01.006_bib40","doi-asserted-by":"crossref","first-page":"530","DOI":"10.3109\/00498254.2011.573018","article-title":"Assessment of UDP-glucuronosyltransferase catalyzed formation of Picroside II glucuronide in microsomes of different species and recombinant UGTs","volume":"41","author":"Li","year":"2011","journal-title":"Xenobiotica"},{"key":"10.1016\/j.trsl.2014.01.006_bib41","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/toxsci\/kfm261","article-title":"Ischemia-reperfusion of rat livers decreases liver and increases kidney multidrug resistance associated protein 2 (Mrp2)","volume":"101","author":"Tanaka","year":"2008","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.trsl.2014.01.006_bib42","doi-asserted-by":"crossref","first-page":"7602","DOI":"10.3748\/wjg.v11.i48.7602","article-title":"Cyclosporine A, FK-506, 40-0-[2-hydroxyethyl]rapamycin and mycophenolate mofetil inhibit proliferation of human intrahepatic biliary epithelial cells in\u00a0vitro","volume":"11","author":"Liu","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.trsl.2014.01.006_bib43","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1365-2125.2006.02509.x","article-title":"A comparison of the effect of cyclosporin and sirolimus on the pharmokinetics of mycophenolate in renal transplant patients","volume":"62","author":"Picard","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.trsl.2014.01.006_bib44","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2710.2008.00906.x","article-title":"No pharmacokinetic interactions between mycophenolic acid and tacrolimus in renal transplant recipients","volume":"33","author":"Kagaya","year":"2008","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.trsl.2014.01.006_bib45","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1177\/0091270009335003","article-title":"Impact of calcineurin inhibitors on urinary excretion of mycophenolic acid and its glucuronide in kidney transplant recipients","volume":"49","author":"Naito","year":"2009","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.trsl.2014.01.006_bib46","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00007691-199902000-00006","article-title":"Evidence that tacrolimus augments the bioavailability of mycophenolate mofetil through the inhibition of mycophenolic acid glucuronidation","volume":"21","author":"Zucker","year":"1999","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.trsl.2014.01.006_bib47","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1124\/dmd.107.017210","article-title":"Glucuronidation of mycophenolic acid by Wistar and Mrp2-deficient TR\u2013 rat liver microsomes","volume":"36","author":"Westley","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.trsl.2014.01.006_bib48","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1078\/0940-2993-00273","article-title":"Can xipamide or tacrolimus inhibit the glucuronidation of mycophenolic acid in rat liver slices?","volume":"54","author":"Balogh","year":"2003","journal-title":"Exp Toxicol Pathol"},{"key":"10.1016\/j.trsl.2014.01.006_bib49","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.clpt.2006.08.002","article-title":"Rifampin induces alterations in mycophenolic acid glucuronidation and elimination: implications for drug exposure in renal allograft recipients","volume":"80","author":"Naesens","year":"2006","journal-title":"Clin Pharmacol Ther"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524414000073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524414000073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T19:08:06Z","timestamp":1688929686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524414000073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S1931524414000073"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2014.01.006","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}